Top Pharma Companies 201227th March
Webinar – MIQE Guidelines26th March
Webinar by TATAA SAB member Steven Bustin ” MIQE Guidelines: A Roadmap for Proper qPCR Experimental Design and Reporting”
qPCR & NGS 201325th March
RNA quality assessment publication15th March
Consortium incl. TATAA publishes results from RNA QC proficiency ring trial
Read the article:
Two senior positions available at TATAA Biocenter14th March
Senior position -within the unit of commissioned services
» Senior Position
Winners in Exiqon’s grant program14th March
TATAA congratulates the winners in Exiqon’s grant program 2013!
Agenda for qPCR-NGS 201314th March
TATAA launches multiplex protein analysis13th March
TATAA launches multiplex protein analysis based on Olink Proseek Multiplex Technology
Smart pipetting assistant – pipetting made easy!
Distractions during pipetting will no longer be a problem. PlatR™ from BioSistemika® is a laboratory device that helps navigating its user when pipetting to a microtiter plate or strips.
PlatR™ runs on a Samsung Galaxy Tab 2 10.1, which is included when ordering PlatR™, and can be used as a regular tablet computer when not needed for pipetting.
Order and more information
Stem cells from ovaries4th March
Stem cells isolated from ovaries of infertile women with non-functional ovaries can be developed into oocyte precursors
TATAA publishes single cell expression profiling study of human oocytes
Now a research team under the leadership of Dr Irma Virant Klun at University Medical Centre in Ljubljana in collaboration with Dr Thomas Skutella at University of Heidelberg and TATAA Biocenter in Göteborg have been successful collecting cells from ovaries of infertile women with premature ovarian failure, grow these in culture under advantages conditions, and, using powerful single cell expression profiling technology, identify among those cells with distinct stem cell and some oocyte-like features. The results are being published in BioMed Research International.
“We are very excited about these finding”, says Irma Virant Klun, “Maybe it is major step towards regaining fertility in the future for a large number of women that today don’t have their own oocytes and cannot get children”. “It is very rewarding to see the first potential clinical applications of the single cell qPCR profiling technique we developed in 2005”, says Dr Mikael Kubista, CEO and founder of the TATAA Biocenter.